Global microbiome therapeutics market to hit $3.2B by 2032, study says

The global microbiome therapeutics market is expected to reach $3.2 billion in revenue by 2032, according to a new study from BIS Research.

The study found that $3.2 billion in revenue by 2032 would show a compound annual growth rate of 24.95 percent within the microbiome therapeutics market. The study suggests that the cause of this growth is due to good manufacturing practices, significant players entering the microbiome sector and the continued reliance on microbiome therapeutics within oncology and the treatment of metabolic disease. 

The study used a compilation of 33 market data tables to reach its conclusions.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars